| 期 |
标题 |
文件 |
| 卷 95, 编号 4 (2023) |
Congratulations from the editors of The Therapeutic Archive |
 (Rus)
|
|
Board E.
|
| 卷 92, 编号 12 (2020) |
Chronic intestinal pseudo-obstruction |
 (Rus)
|
|
Parfenov A., Krums L., Bykova S., Ahmadullina O.
|
| 卷 92, 编号 12 (2020) |
Recommendations for the Protocol of functional examination of the anorectal zone and disorders classification: the International Anorectal Physiology Working Group consensus and Russian real-world practice |
 (Rus)
|
|
Fomenko O., Morozov S., Scott S., Knowles H., Morozov D., Shelygin Y., Maev I., Nikityuk D., Shkoda A., Kashnikov V., Bordin D., Isakov V., Biryukov O., Belousova S., Pimenova E., Rumiantsev A., Fedorov E., Gvozdev M., Trukhmanov A., Storonova O., Indeykina L., Biryukova M., Andreev D., Kucheryavyy Y., Achkasov S.
|
| 卷 92, 编号 12 (2020) |
Pericarditis in contemporary therapeutic clinic: nosological spectrum, approaches to diagnosis and treatment |
 (Rus)
|
|
Blagova O., Nedostup A., Sedov V., Kogan E., Alijeva I., Sorokin G., Sarkisova N.
|
| 卷 92, 编号 12 (2020) |
Autoimmunity and autoinflammation in pathogenesis of immunoinflammatory diseases |
 (Rus)
|
|
Shilkina N., Masina I., Dryazhenkova I., Vinogradov A., Yunonin I.
|
| 卷 92, 编号 12 (2020) |
Detection of kidney dysfunction potential biomarkers with hypertension in the persons of 25–45 years |
 (Rus)
|
|
Kovalkova N., Khudyakova A., Kashtanova E., Polonskaya Y., Shcherbakova L., Ragino Y.
|
| 卷 92, 编号 12 (2020) |
The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases |
 (Rus)
|
|
Vasil'ev V., Chal'tsev B., Gorodetskii V., Pal'shina S., Shornikova N., Anan'eva L., Gaiduk I., Kokosadze N., Probatova N., Pavlovskaia A., Rodionova E., Safonova T., Balabina A.
|
| 卷 92, 编号 12 (2020) |
Association of rs3025058 polymorphism with the development of stroke in patients with cardiovascular pathology |
 (Rus)
|
|
Nikulina S., Shulman V., Chernova A., Prokopenko S., Nikulin D., Platunova I., Tretyakova S., Semenchukov A., Marilovtseva O., Lebedeva I., Maksimov V., Gurazheva A.
|
| 卷 92, 编号 12 (2020) |
Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation |
 (Rus)
|
|
Allazova S., Novikova M., Kotenko O., Shilov E.
|
| 卷 92, 编号 12 (2020) |
Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease |
 (Rus)
|
|
Vakhrushev Y., Suchkova E., Lukashevich А.
|
| 卷 92, 编号 12 (2020) |
Comparative capabilities of the speckle-tracking echocardiography technologiesin two-dimensional and three-dimensional modes in the detection of subclinical cardiotoxicity in patients with breast cancer |
 (Rus)
|
|
Saidova M., Avalyan A., Oshchepkova E., Shitov V., Chazova I.
|
| 卷 92, 编号 12 (2020) |
Resected bowel syndrome: clinical course and treatment options |
 (Rus)
|
|
Hatkov I., Kuzmina T., Sabelnikova E., Parfenov A.
|
| 卷 92, 编号 12 (2020) |
Experience of olokizumab use in COVID-19 patients |
 (Rus)
|
|
Antonov V., Ignatova G., Pribytkova O., Sleptsova S., Strebkova E., Khudyakova E., Simakov A., Rabets S., Tikhonova E., Kurmaeva D., Petrushin M., Mashkov A., Gayazova E., Yasheva I., Andreev M., Khinovker V., Karpunin A., Berezhanskiy B.
|
| 卷 92, 编号 12 (2020) |
The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis |
 (Rus)
|
|
Maev I., Andreev D., Kucheryavyy Y., Levchenko A.
|
| 卷 92, 编号 12 (2020) |
Evaluation of the clinical efficacy of local antibacterial therapy in the treatment of acute bacterial rhinosinusitis |
 (Rus)
|
|
Banashek-Meshcheriakova T., Semyonov F.
|
| 卷 92, 编号 12 (2020) |
Anemia as a risk factor of contrast-associated acute kidney injury |
 (Rus)
|
|
Mironova O., Deev A., Lakotka P., Fomin V.
|
| 卷 92, 编号 12 (2020) |
The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection |
 (Rus)
|
|
Lioznov D., Tokin I., Zubkova T., Sorokin P.
|
| 卷 92, 编号 12 (2020) |
Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis |
 (Rus)
|
|
Kucheryavyy Y., Andreev D., Maev I.
|
| 卷 92, 编号 12 (2020) |
Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе |
 (Rus)
|
|
Khokhlov A., Mariandyshev A., Shcherbakova V., Ozerova I., Kazaishvili Y., Igumnova O., Bolgarina A., Rudoy B.
|
| 卷 92, 编号 12 (2020) |
Testing and validation of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL |
 (Rus)
|
|
Ionova T., Zinkovskaya A., Mayevskaya E., Nikitina T., Porfirieva N., Cheremushkina N., Shaburov R., Kucheryavyy Y., Maev I.
|
| 卷 92, 编号 12 (2020) |
Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma |
 (Rus)
|
|
Zyryanov S., Avdeev S., Ivanov D., Zhuravleva M., Kniajeskaia N., Matveev N., Nenasheva N., Fomina D., Frolov M.
|
| 卷 92, 编号 12 (2020) |
Vascular remodeling with violations of intracardiac hemodynamics in patients older age category, combined with the clinical-cluster, neurocognitive and biomarker heterogeneity in multifocal atherosclerosis |
 (Rus)
|
|
Khasanov A., Bakirov B., Davletshi R., Novikova L., Kudlay D.
|
| 卷 92, 编号 12 (2020) |
Clinical case of combined genetic pathology in a patient |
 (Rus)
|
|
Losik E., Yakushina I., Skhirtladze M., Balahonova N., Kerchev V., Garanina I.
|
| 卷 92, 编号 12 (2020) |
Antiresorptive activity of pharmacological chondroitin sulfate in the older age group |
 (Rus)
|
|
Shavlovskaya O., Zolotovskaya I., Prokofyeva Y.
|
| 卷 92, 编号 12 (2020) |
Adrenal incidentaloma. Part 1. Computed tomography of adrenal incidentaloma: the possibilities and difficulties of differential diagnosis |
 (Rus)
|
|
Buryakina S., Tarbaeva N., Volevodz N., Karmazanovsky G., Kovalevich L., Shestakova M., Dedov I.
|
| 卷 92, 编号 12 (2020) |
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia |
 (Rus)
|
|
Shmalts A., Gorbachevsky S.
|
| 卷 92, 编号 12 (2020) |
BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic |
 (Rus)
|
|
Kalyuzhin O., Andronova T., Karaulov A.
|
| 卷 92, 编号 12 (2020) |
Diagnosis and treatment of hereditary angioedema with normal C1-inhibitor level |
 (Rus)
|
|
Emelyanov A., Leshenkova E., Kameneva G.
|
| 卷 92, 编号 12 (2020) |
Insulin therapy is a personalized approach to glycemic management in diabetes |
 (Rus)
|
|
Demidova T., Titova V.
|
| 卷 92, 编号 12 (2020) |
Mixed steatohepatitis: more questions than answers (Part 1) |
 (Rus)
|
|
Raikhelson K., Kondrashina E., Pazenko E.
|
| 卷 92, 编号 12 (2020) |
Diagnosis of thrombotic thrombocytopenic purpura |
 (Rus)
|
|
Galstyan G., Klebanova E.
|
| 卷 92, 编号 12 (2020) |
Rebamipide: evidence base for use in gastroenterology |
 (Rus)
|
|
Andreev D., Maev I.
|
| 卷 91, 编号 6 (2019) |
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease |
 (Rus)
|
|
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
|
| 卷 91, 编号 6 (2019) |
Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study |
 (Rus)
|
|
Milovanova L., Kozlovskaya(Lysenko) L., Androsova T., Lebedeva M., Taranova M., Milovanova S., Kondratyeva T., Zubacheva D., Tchebotareva N., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
|
| 卷 91, 编号 6 (2019) |
Clinical and pathologic features of nephropathy with C1q deposits |
 (Rus)
|
|
Chebotareva N., Vinogradov A., Grishina A., Kozlovskaya(Lysenko) L., Varshavsky V.
|
| 卷 91, 编号 6 (2019) |
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease |
 (Rus)
|
|
Bolotova E., Dudnikova A.
|
| 卷 91, 编号 6 (2019) |
Modern approaches to the detection of monoclonal gammopathy of undetermined significance (MGUS) in patients with kidney diseases |
 (Rus)
|
|
Kozlovskaya(Lysenko) L., Chebotareva N., Mrykhin N., Rameev V., Androsova T., Roshchupkina S., Maryina S., Kogarko I., Kogarko B.
|
| 卷 91, 编号 6 (2019) |
Polyvascular disease in patients with myocardial infarction and chronic kidney disease |
 (Rus)
|
|
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
|
| 卷 91, 编号 6 (2019) |
Protein - energy wasting of haemodialysis patients |
 (Rus)
|
|
Jakovenko A., Rumyantsev A.
|
| 卷 91, 编号 6 (2019) |
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease |
 (Rus)
|
|
Taranova M., Milovanova L., Kozlovskaya(Lysenko) L., Milovanova S., Androsova T., Zubacheva D., Lebedeva M., Dobrosmyslov I., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
|
| 卷 91, 编号 6 (2019) |
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease |
 (Rus)
|
|
Murkamilov I., Sabirov I., Fomin V., Aitbaev K., Murkamilova Z.
|
| 卷 91, 编号 6 (2019) |
Difficulties in diagnosing the syndrome of "aorto - mesenteric tweezers" (nutcracker syndrome) in a patient with macrogematuria |
 (Rus)
|
|
Grigoryeva E., Senichkina M., Maiorova A., Kiseleva O.
|
| 卷 91, 编号 6 (2019) |
Russian Therapeutic School: D.D. Pletnev, A.L. Myasnikov, E.I. Chazov |
 (Rus)
|
|
Chuchalin A.
|
| 卷 91, 编号 6 (2019) |
Atrial myocarditis in a patient with Takayasu arteritis |
 (Rus)
|
|
Safiullina A., Uskach T., Zhirov I., Pogorelova O., Stukalova O., Gaman S., Gramovich V., Novikov P., Tereshchenko S.
|
| 卷 91, 编号 6 (2019) |
Academician E.I. Chazov’s contribution to cardiology |
 (Rus)
|
|
Oschepkova E.
|
| 卷 91, 编号 6 (2019) |
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review) |
 (Rus)
|
|
Strizhakov L., Fomin V., Garipova R., Babanov S., Arkhipov E., Lebedeva M.
|
| 卷 91, 编号 6 (2019) |
Recent advances in diagnosis and management of atrial fibrillation |
 (Rus)
|
|
Mironov N., Laiovich L., Mironova E., Sharf T., Aparina O., Mironova N., Stukalova O., Yuricheva Y., Sokolov S., Novikov I., Maykov E., Pevzner A., Golitsyn S.
|
| 卷 91, 编号 6 (2019) |
Modern approaches to conservative therapy of polycystic kidney disease |
 (Rus)
|
|
Rudenko T., Bobkova I., Stavrovskaya E.
|
| 卷 91, 编号 6 (2019) |
Antithrombotic therapy of coronary heart disease: time - tested essential principles |
 (Rus)
|
|
Panchenko E.
|
| 卷 91, 编号 6 (2019) |
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment |
 (Rus)
|
|
Milovanova S., Kozlovskaya(Lysenko) L., Milovanova L., Gordovskaya N., Ignatova T., Taranova M., Androsova T.
|
| 卷 91, 编号 6 (2019) |
The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works |
 (Rus)
|
|
Shakhnovich R., Ruda M.
|
| 卷 91, 编号 6 (2019) |
Circulating microRNAs as potential biomarkers of chronic kidney disease |
 (Rus)
|
|
Aitbaev K., Murkamilov I., Fomin V.
|
| 卷 91, 编号 6 (2019) |
Burden, access, and disparities in kidney disease |
 (Rus)
|
|
Crews D., Bello A., Saadi G.
|
| 卷 91, 编号 6 (2019) |
Diagnosis and treatment of myocardial infarction in patient with end - stage renal disease on chronic hemodialysis |
 (Rus)
|
|
Antukh D., Shchekochikhin D., Nesterov A., Gilarov M.
|
| 1 - 54 的 54 信息 |
|